379 related articles for article (PubMed ID: 11927625)
1. c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity.
Arbour N; Naniche D; Homann D; Davis RJ; Flavell RA; Oldstone MB
J Exp Med; 2002 Apr; 195(7):801-10. PubMed ID: 11927625
[TBL] [Abstract][Full Text] [Related]
2. c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation.
Conze D; Krahl T; Kennedy N; Weiss L; Lumsden J; Hess P; Flavell RA; Le Gros G; Davis RJ; Rincón M
J Exp Med; 2002 Apr; 195(7):811-23. PubMed ID: 11927626
[TBL] [Abstract][Full Text] [Related]
3. Defective antiviral CD8 T-cell response and viral clearance in the absence of c-Jun N-terminal kinases.
Wang YQ; Ma X; Lu L; Zhao L; Zhang X; Xu Q; Wang Y
Immunology; 2014 Aug; 142(4):603-13. PubMed ID: 24673683
[TBL] [Abstract][Full Text] [Related]
4. Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.
Zhou S; Cerny AM; Fitzgerald KA; Kurt-Jones EA; Finberg RW
J Virol; 2012 Oct; 86(20):11254-65. PubMed ID: 22875973
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation.
Sabapathy K; Hochedlinger K; Nam SY; Bauer A; Karin M; Wagner EF
Mol Cell; 2004 Sep; 15(5):713-25. PubMed ID: 15350216
[TBL] [Abstract][Full Text] [Related]
6. c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation.
Sabapathy K; Kallunki T; David JP; Graef I; Karin M; Wagner EF
J Exp Med; 2001 Feb; 193(3):317-28. PubMed ID: 11157052
[TBL] [Abstract][Full Text] [Related]
7. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
[TBL] [Abstract][Full Text] [Related]
8. Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus.
Binder D; van den Broek MF; Kägi D; Bluethmann H; Fehr J; Hengartner H; Zinkernagel RM
J Exp Med; 1998 Jun; 187(11):1903-20. PubMed ID: 9607930
[TBL] [Abstract][Full Text] [Related]
9. CD40L expression by CD4
Durlanik S; Loyal L; Stark R; Sercan Alp Ö; Hartung A; Radbruch A; von Herrath M; Matzmohr N; Frentsch M; Thiel A
Eur J Immunol; 2016 Nov; 46(11):2566-2573. PubMed ID: 27562840
[TBL] [Abstract][Full Text] [Related]
10. Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection.
Zhou S; Ou R; Huang L; Moskophidis D
J Virol; 2002 Jan; 76(2):829-40. PubMed ID: 11752172
[TBL] [Abstract][Full Text] [Related]
11. Role of PKR and Type I IFNs in viral control during primary and secondary infection.
Nakayama Y; Plisch EH; Sullivan J; Thomas C; Czuprynski CJ; Williams BR; Suresh M
PLoS Pathog; 2010 Jun; 6(6):e1000966. PubMed ID: 20585572
[TBL] [Abstract][Full Text] [Related]
12. The role of MKK4 in T-cell development and immunity to viral infections.
Preston SP; Doerflinger M; Scott HW; Allison CC; Horton M; Cooney J; Pellegrini M
Immunol Cell Biol; 2021 Apr; 99(4):428-435. PubMed ID: 33175451
[TBL] [Abstract][Full Text] [Related]
13. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.
Holst PJ; Christensen JP; Thomsen AR
J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263
[TBL] [Abstract][Full Text] [Related]
14. Antiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements.
Whitmire JK; Murali-Krishna K; Altman J; Ahmed R
Philos Trans R Soc Lond B Biol Sci; 2000 Mar; 355(1395):373-9. PubMed ID: 10794058
[TBL] [Abstract][Full Text] [Related]
15. Mast Cells Modulate Antigen-Specific CD8
Hackler Y; Siebenhaar F; Löhning M; Maurer M; Muñoz M
Front Immunol; 2021; 12():688347. PubMed ID: 34194439
[TBL] [Abstract][Full Text] [Related]
16. Enhanced CD8 T cell responses through GITR-mediated costimulation resolve chronic viral infection.
Pascutti MF; Geerman S; Slot E; van Gisbergen KP; Boon L; Arens R; van Lier RA; Wolkers MC; Nolte MA
PLoS Pathog; 2015 Mar; 11(3):e1004675. PubMed ID: 25738498
[TBL] [Abstract][Full Text] [Related]
17. IRF9 Prevents CD8
Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
[TBL] [Abstract][Full Text] [Related]
18. Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus.
Hofer MJ; Li W; Manders P; Terry R; Lim SL; King NJ; Campbell IL
J Virol; 2012 Jun; 86(12):6932-46. PubMed ID: 22496215
[TBL] [Abstract][Full Text] [Related]
19. Multiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunity.
Eberlein J; Davenport B; Nguyen TT; Victorino F; Sparwasser T; Homann D
J Virol; 2012 Feb; 86(4):1955-70. PubMed ID: 22156513
[TBL] [Abstract][Full Text] [Related]
20. Persistent virus infection despite chronic cytotoxic T-lymphocyte activation in gamma interferon-deficient mice infected with lymphocytic choriomeningitis virus.
Bartholdy C; Christensen JP; Wodarz D; Thomsen AR
J Virol; 2000 Nov; 74(22):10304-11. PubMed ID: 11044074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
